Healthcare Expert With 30 Years Experience
Contributor's Links: Dr KKD Healthcare Stock Tips

KKD Healthcare Analytics is a niche healthcare investment advisory service. Our goal is to channel our medical knowledge and long track record as a private investor into a website that will be the ultimate go-to place for knowledge and information about biotech ... more

ALL CONTRIBUTIONS

Biotech Digest – XENT Gets FDA Approval, AGN Announces Acquisition, IONS Licenses Product
Intersect ENT Inc. reported the FDA approval for its SINUVA implant, designed to be used for treating recurrent nasal polyps in patients who have had previous ethmoid sinus surgery.
Read
Biotech Digest – KTOV Buys Stake, JNJ Reports Positive Results, NVS Receives CE Mark
Kitov Pharmaceuticals announced that it has acquired an additional 27% stake in privately held TyrNovo, a developer of small molecule oncology drugs.
Read
Biotech Digest – INSM Reports Positive Data, MRK Gets EC Approval, LCI Receives FDA Approval
Oramed Pharmaceuticals reported the successful conclusion of its meeting with the FDA with regard to its drug candidate ORMD-0801. Insmed (INSM) stock jumped over 100 percent in the pre-market session.
Read
Biotech Digest – IMDZ Reports Data, JNJ Terminates Collaboration
Immune Design announced interim top line data from a Phase 2 clinical trial assessing the combination of its CMB305 and Roche's Tecentriq (atezolizumab) compared to Tecentriq alone in 88 soft tissue sarcoma patients.
Read
Biotech Digest – URGN Receives Fast Track Designation, MDVX Receives Australian Approval, AZN Inks A New Deal
UroGen Pharma announced that the FDA has designated its MitoGel for Fast Track review for the treatment of patients with low-grade upper urinary tract urothelial carcinoma. AstraZeneca inked a new deal with Takeda Pharmaceutical.
Read
Biotech Digest – GMED Receives Clearance, BIOC Inks New Collaboration, PFE Receives Approval
Globus Medical Inc. stock perked up as the company announced receiving the 510 (k) clearance from the FDA for Excelsius GPS. AstraZeneca announced receiving the FDA approval for its Lynparzaa. Pfizer has FDA approval for its Besponsa.
Read

STOCKS I FOLLOW

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications